BRISBANE, Calif., March 20, 2014 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, is unveiling two new systems at the 72nd American Academy of Dermatology conference in Denver, Colorado, held from March 21-25, 2014.
These two new products are the Company's latest innovations targeted to core physicians for the hair removal, tattoo removal and benign pigmented lesion segments of the growing aesthetic market:
- excel HRTM is the world's first premier hair removal laser system to feature dual wavelengths (755 nm/1064 nm) combined with best-in-class sapphire contact cooling for enhanced patient safety, efficacy, and comfort. It allows practitioners to treat all skin types with a modern and ergonomically designed system. Further, there are no consumables and it has a lower operating cost, compared to traditional hair removal systems. excel HR has received 510(k) clearance by the Food and Drug Administration and is expected to commence commercial shipments in the second quarter of 2014 with significant revenue contributions occurring in the second half of 2014.
- enlightenTMis the world's first and only laser platform featuring dual wavelength (532 nm/1064 nm) and both picosecond and nanosecond pulse durations to effectively and efficiently clear a wide range of tattoo colors, ink compositions and pigment concerns. enlighten has received the CE Mark in Europe and is currently pending 510(k) clearance by the Food and Drug Administration and is not available for commercial sale in the U.S. at the present time. We expect to commence commercial shipments in the second half of 2014 (with U.S. shipments subject to FDA clearance).
Kevin Connors, President and CEO of Cutera stated, "These new product launches, combined with the investments we are making in our commercial operations, strategically position us for revenue growth in the second half of 2014. Both excel HR and enlighten continue the market-enabling and pioneering technological innovation of our best-selling excel V vascular laser system. Given laser hair removal's top position in aesthetic energy-based treatments, we are excited to expand our portfolio with excel HR. The enlighten product is a pinnacle achievement for our engineering team and introduces many 'industry first' technologies with modern design."
E. Victor Ross, M.D., a board certified Dermatologist at Scripps Clinic in San Diego and one of the leading experts in aesthetic laser technology commented "excel HR and enlighten integrate proven laser wavelengths and treatment parameters with pioneering innovations that have great potential to shift treatment paradigms. In particular, enlighten, with its dual wavelength and selectable dual pulse design, has great applicability for improved clearance of tattoos and benign epidermal and dermal pigmented lesions."
Attendees at the 2014 American Academy of Dermatology conference can experience the official unveiling of these new systems on Saturday, March 22 at 10:30 AM at Booth #1129.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning new products features, effectiveness, treatable conditions, ability to obtain regulatory approvals, expected date of commercial availability, the size and growth of the aesthetic market are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements are described in the section entitled, "Risk Factors" in the Company's most recent Form 10-K as filed with the Securities and Exchange Commission on March 18, 2014. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
CONTACT: Cutera, Inc. Ron Santilli Chief Financial Officer 415-657-5500 Investor Relations John Mills Integrated Corporate Relations, Inc. 310-954-1105 firstname.lastname@example.orgSource:Cutera, Inc.